Story perspectives

Jameela Jamil Slams Serena Williams' GLP-1 Drug Endorsement

8/26/2025

42 7

Summary

Jameela Jamil Critiques

Jameela Jamil criticized Serena Williams for endorsing GLP-1 weight loss drugs following her 31-pound weight loss.
Jamil raised concerns about celebrities' healthcare access and the risks associated with these medications.
She highlighted severe side effects, such as paralysis, cancer, and depression, advocating for caution and better healthcare access before using these drugs.

Summary

Serena's Weight Loss Advocacy

Serena Williams lost 31 pounds using GLP-1 weight loss medication after postpartum struggles.
She initiated a campaign with Ro to promote transparency about weight loss drugs.
Critics raise ethical concerns about her endorsement, citing her husband's investment in Ro and GLP-1 risks.
Experts worry about the implications for mothers regarding body image and weight management.
Williams highlighted difficulties in losing weight despite maintaining a healthy lifestyle.

1 of 2

Jameela Jamil Critiques

Jameela Jamil criticized Serena Williams for endorsing GLP-1 weight loss drugs following her 31-pound weight loss.
Jamil raised concerns about celebrities' healthcare access and the risks associated with these medications.
She highlighted severe side effects, such as paralysis, cancer, and depression, advocating for caution and better healthcare access before using these drugs.

1 / 2